STANDARDIZATION OF AMUKKARA CHOORANUM- SIDDHA DRUG
HTML Full TextSTANDARDIZATION OF AMUKKARA CHOORANUM- SIDDHA DRUG
Kiruthika Saravanan, Sharulatha Venugopal * and R. Shilpa
Department of Chemistry, Avinashilingam Institute for Home Science and Higher Education for Women- Coimbatore, Tamil Nadu, India.
ABSTRACT: Siddha medicine originated from Tamil culture in southern India. Worldwide there are 75% of herbal plants are used for AYUSH and Allopathy medicines. Amukkara Choornam is a polyherbal Siddha formulation. Amukkara Choornam has anti-arthritic activity, and it helps to cure rheumatoid arthritis. The demand for Siddha medicines in India is increasing daily; we have to overcome some problems like quality control issues, processing, administrative issues, and clinical trials. From the above, quality control issues are the most important ones. The quality, safety and, side effects, knowledge about herbs can be determined while standardizing each herbal formulation. The knowledge about the herbs and herbal medicines by the villagers and tribes is unknown to scientists. Scientists are well-known about the standardization process unknown by rural peoples and tribes. Hence the present study is carried out to identify the bioactive phytochemical constituents present in Amukkara Choornam by spectroscopic analysis. Standardization is a tool in the quality control process must for rural health care. Siddha medicines are our traditional medicines, which have lesser side effects. Since, it is a plant-based product.
Keywords: Siddha, Amukkara Chooranam, Rheumatoid arthritis, Anti-arthritic, Flavonoids
INTRODUCTION: India is one of the mammoths of biodiversity countries; its tradition is related to using herbs as medicine. In the present situation, there is a growing demand for herbal products in the global pharmaceutical market. Hence pharmaceutical companies thrive research on plant-based compounds for their potential 3-4. Herbal medicines are preferred over allopathy medicines because of their widespread availability, lower cost, effectiveness with chronic conditions, reduced risk of side effects, and may be safer to use over time 5.
The Siddha system of medicine is the oldest Indian medicine system. Siddha is the mother medicine for all the Indian systems of medicine 1. It has been practiced mostly in the southern part of this country for treating various ailments and chronic diseases 6. According to Siddha, the first third of life is predominated by wind, the first third of life, the second third by bile, and the last third by phlegm. The greatest emphasis on examining the pulse is given for diagnosis by Siddha experts 7.
A literature search revealed that three reports on the scientific validation of Amukkara Chooranum deal with the physicochemical and HPTLC assessment of the Chooranum 8, 9, 10. The authors (D. Sivaraman et al.,) demonstrated Amukkara Chooranum for strong antilithogenic effects due to therapeutic phytochemicals interacting with ions that produce urolithiasis crystals and prevent their formation and aggregation 11. Amukkara Chooranum Tablet was one of the Siddha Sasthric Medicines in Fixed Regimen (SSM-FiRe) given to the COVID - 19 patients with asymptomatic and mild symptomatic category as an oral dose and the regimen had safe, no modification in biochemical parameters 12. Amukkara Chooranum inhibited biofilm formation against Candida albicans with a concentration of 20 µg/ml and demonstrated a 60% inhibition 13. Diabetes can be lowered by using Amukkara Chooranum regularly as an aduvant in Rasa Chendruram 14. Sulekha reported Amukkara remedy for diseases and infections specific to women’s health 15. Amukkara Chooranam Mathirai possesses anti-diarrheal activities and helps to minimize depressive symptoms while receiving treatment for COVID-19 in TPEC COVID care center at Vellore 16. A commercial sample of AMC was investigated and validated in the present work for its organoleptic characteristics, physico - chemical characteristics, and flavonoid content. GC-MS chromatographic and IR, NMR spectral fingerprint and thermogravimetry analysis have been documented in this paper.
Standardization of Siddha Medicine: Knowledge about the herbs and herbal medicines by the villagers and tribes is unknown to scientists. Standardization is required for herbal medicines to ascertain their quality, safety, and side effects. Inherent characteristics, definitive qualitative and quantitative analysis, and constant parameters of herbal medicines can be done through standardization. Quantitative and qualitative analysis of herbal medicines helps to improve efficacy, safety, and reproducibility 17.
Standardization involves the development of technical standard methods for herbal drugs and is the tool to improve the quality control process 2. The technical methods for standardization of herbal drugs include chromatographic and spectroscopic analysis, chemical parameters, microbiological parameters, pharmacognostic evaluation, physicochemical parameters etc. 11.
Polyherbal Siddha medicine, named Amukka-rachoornam is composed of herbs and spices. The named components are Withania somnifera, Piper longum, Syzygium aromaticum, Cinnamomum wightii, Elettaria cardamomum, Piper nigrum, Zingiber officinale, and cane sugar 18. It is an anti-arthritic active compound prescribed for diseases like rheumatoid arthritis, kapharoga, splenomegaly, vataroga, hiccup, tuberculosis, anemia, leucorrhoea. It aids in secreting bile for better digestion and kapha balance 19.
MATERIALS AND METHODS: In the present study, the evaluation of Amukkara Chooranum was carried out by standard methods. The drug was collected from Siddha drug suppliers, Coimbatore district. The test sample is designed here in after as AMC (Amukkara Chooranum).
Organoleptic Properties: Organoleptic property of the purchased drug was examined according to the conventional method given by Kokate 20. Organoleptic characteristics like colour, odour, appearance and taste were evaluated.
Physico- Chemical Properties: The solubility of the sample was tested using solvents like water, dichloro methane, ethyl acetate, ethyl alcohol, DMSO, acetone, chloroform, pet ether, and concentrated acids, and the characteristic changes were noted.
For the solubility test, a small amount of the samples were treated individually with water, concentrated hydrochloric acid, nitric acid, concentrated sulphuric acid, 5% aqueous sodium hydroxide, iodine solution, 5% aqueous potassium hydroxide solution and the glacial acetic acid solution respectively.
The ash value, pH value, and loss on drying were determined as per the method described in Indian Pharmacopoeia 21. The sample's melting point was determined using melting point apparatus (Saffire). The pH value of the sample was determined by a pH meter (QC/Micro/pH – 101, Sr No. 1311605).
Loss on Drying: Accurately, 2 gram of the sample was taken in a tared crucible, and initial weight was taken. The sample was heated in a Muffle furnace maintained at 105-110°C, for 3 h, after which the sample was allowed to cool to room temperature for 30 minutes in desiccators and subsequently weighed. This procedure was repeated until a constant weight was obtained.
Loss on drying (%) = W / Loss in weight x 100
Where W = weight of the sample powder in g.
Total Ash Value: Accurately 2 to 3 g of air–dried samples of the AMC was weighed in a silica dish and incinerated at a temperature not exceeding 700°C until ash free from carbon was obtained. Then it was cooled and weighed. The process was repeated until at least two consecutive constant weights were obtained. The results were expressed as range or mean value ± standard deviation. The percentage of ash was calculated with reference to the air–dried drug.
Ash % = W / Loss in weight x 100
W = weight of the air-dried drug.
Phytochemical Screening: To identify the phytochemicals present in the sample phytochemical colour test was carried out according to the standard methods 22.
Quantitative Estimation of Total Flavonoids: Total flavonoid content was determined by standard method 22. The ethanol extract of the sample (0.5ml) was mixed with a freshly prepared 2% ethanolic solution of aluminium chloride. This mixture was incubated at room temperature for 60 minutes. A yellow colour developed, indicating the presence of flavonoids in the sample. The absorbance was measured by UV-VIS spectro-photometer at 420nm.
Generally, total flavonoids in the plant samples will be expressed as quercetin equivalent (mg/g). Based on the calibration curve, the total flavonoid content was calculated using the formula,
Y = (0.217) × (X)
Where X is the absorbance and Y is the quercetin equivalent.
Thermo Gravimetry Analysis (TGA): Thermo gravimetric analysis was conducted using a TA instrument 951 thermo gravimetric analyser (TGA). The 951 model is a horizontal design TGA. Each test was conducted with a flow rate of 50cc/ min of nitrogen through the furnace and balance sides of the TGA. Approximately 6 – 12 mg of the sample was weighed onto a platinum pan for each sulphate decomposition test. The sample was then held at ambient conditions for 40 min before it was heated at a rate of 5°C/ min to 200°C where the temperature was held for 1 hour. The sample was then heated at the same heating rate to 300°C and held for 15 min this step was then repeated, raising the temperature in 1000C increments and holding for 15 min until a temperature of 700°C was reached (that is 100°C, 200°C, 300°C, 400°C, 500°C, 600°C and 700°C). The final step in the decomposition program was to increase the temperature to 700°C at a rate of 5°C/ min where the temperature was held for 15 min.
Spectroscopic Analysis: The UV-Visible, Infra-Red and NMR spectral fingerprints were recorded for the sample. UV – Visible spectrum was recorded using Science World AU - 2701. The IR of AMC was recorded using Affinity – I Shimatzo FT – IR instrument. GC-MS analysis was performed using the Clarus 680 GC. The H1NMR of AMC was recorded in 500 MHz Bruker Avance NMR instrument, using DMSO solvent.
RESULT AND DISCUSSION:
Organoleptic Properties: Organoleptic property includes the study of morphology and other sensory characteristics like the drug's shape, size, and fracture. The results were summarized in Table 1.
TABLE 1: RESULTS OF ORGANOLEPTIC CHARACTERISTICS OF AMC
Parameters | Observation |
Colour | Light Brown |
Odour | Dried Ginger Smell |
Taste | Sweet |
State of Drug | Powder |
Consistency | Soft |
Physico Chemical Properties: The solubility of the drug in aqueous media in the pH range of 1-7.5 is important for the efficient release of the drug when it is administered orally 23.
Hence, the behavior of the drug in acidic, basic, and neutral reagents was observed. The sample was soluble in concentrated hydrochloric acid and Partially Soluble in nitric and sulphuric acid. The sample was insoluble in an iodine solution and glacial acetic.
The solubility of a drug is an important biopharmaceutical parameter as it affects the rate of dissolution and thus affects the rate of absorption. The AMC was found to be partially soluble in ethanol and chloroform and soluble in DMSO.
TABLE 2: SOLUBILITY OF AMC
Chemical treatment | Observation |
Concentrated Hydrochloric acid | Soluble |
Concentrated Nitric acid | Partially soluble |
Concentrated Sulphuric acid | Partially Soluble |
5% Aqueous Sodium Hydroxide | Insoluble |
Iodine Solution | Insoluble |
5% Aqueous Potassium Hydroxide | Insoluble |
Glacial Acetic Acid | Insoluble |
Chloroform | Partially soluble |
Ethanol | Partially Soluble |
DMSO | Soluble |
The melting point of the drug was 260°C. pH of the formulation plays a significant role in the living biological system with respect to aiding in absorption and distribution through systemic circulation. The pH of the sample was found to be 7.0-7.1. Hence, the sample is neutral. Ash value was found to be 0.0438%. At higher temperature the sample charred, which indicated the presence of organic matter and the absence of inorganic salts. Loss on drying of the sample was carried out using muffle furnace maintained at 105-110°C and the loss on drying was found to be 0.3618%, indicating AMC's low moisture content.
FIG. 1: ASH VALUE AND LOSS ON DRYING OF AMC
Phytochemical Screening: The colour tests of the sample indicated the presence of alkaloids, flavonoids, and carbohydrates in the polyherbal formulation AMC.
Quantitative Estimation of Total Flavonoids: Many herbs and plant products have been shown to have hypoglycemic action. Flavonoids are known to be bioactive antidiabetic principles. Flavonoid compounds such as Boswellic acid, Ellagic acid, Quercetin, and Rutin revealed a maximum reduction in blood glucose levels 24.
The quantitative estimation of flavonoids was done by the method described by Ordonez et al., 25 based on the formation of a flavonoid-aluminum complex. The results showed that 0.328mg/1g of flavonoid was in the sample by Ordonez method.
TGA Analysis: Thermal analysis is a technique used to study the properties of a material with temperature change. Fig. 2 and 3 represent the TG curve of the sample. The weight loss commenced at 203°C and completely decreased at 575°C above that; the curve observed no change in weight. The Derivative thermo-gravimetric (DTG) curve showed the exothermic nature of AMC, as reported in Fig. 4 and 5, indicating two decomposition peaks at 190°C and 512°C.
The DTG of organic matter usually shows three exothermic peaks due to oxidation i.e., recalcitrant organic matter (380°C – 475°C), refractory organic matter including black carbon and labile organic matter (200°C – 380°C) 26. In the DTG curve of AMC Fig. 6, the regions corresponding to the peak at 300°C and 450°C are due to aliphatic, carboxylic acids, and aromatic groups. The aliphatic content was 139%, and the aromatic content was 75%.
FIG. 2: TG CURVE OF AMC
FIG. 3: TG CURVE OF AMC
FIG. 4: DTA CURVE OF AMC
FIG. 5: DTA CURVE OF AMC
FIG. 6: DTG CURVE OF AMC
FT – IR: IR spectrum Fig. 7 indicated the presence of amides, alcohols/phenols, amines, and alkyl halides in the AMC sample Table 3, which may be due to the presence of plant ingredients used in the AMC sample.
TABLE 3: IR RANGE OF AMC
Frequency | Peak Assignment | Possibility |
3329.14, 1612.49 | N-H Stretching (strong), N-H Bending for 10&2oamides | Amides |
3329.14, 1411.87, 1029.99 | O-H Bond is broad, C-O-H Bending appears broad (weak), C-O Stretching | Alcohols & Phenols |
3329.14, 1334.74 | N-H Stretching, C-N Stretching | Amines |
586.36 | C-Br stretching (strong) | Alkyl halide |
FIG. 7: IR FINGERPRINTING OF AMC
GC-MS: The GC–MS chromatogram of the formulation is shown in Fig. 8, 9, 10, 11, 12, and 13. The spectrum showed nine major peaks. The compounds pertaining to the peaks were identified by comparing with NIST library data of the peaks and mass spectra of the peaks with those reported in the literature. The following compounds were identified in AMC viz, Chrysoeriol, Apigenin, Adipic acid, Piperine, and Squalene Fig. 18, 19, 20, 21, 22. Table 4 indicates the identified compounds and their uses.
FIG. 8: GC SPECTRUM OF AMC
FIG. 9:
FIG. 10:
FIG. 11:
FIG. 12:
FIG. 13:
FIG. 9, 10, 11, 12, and 13: MASS-SPECTRUM OF AMC
TABLE 4: STRUCTURE OF IDENTIFIED CONSTITUENTS IN THE AMC BY GC – MS ANALYSIS
RT | Area% | Molecular Weight | GC–ESI–MS | Identified Compound | Nature & Uses |
26.478 | 19.575 | 285.343g/mol | MS: 285.18,207.01, | Pungent, increase | |
173.12,137.12, | Piperine Figure-18 | the bioavailability | |||
115.16,71.11. | of nutritional compounds | ||||
21.406 | 10.537 | 146.142g/mol | MS: 103.1,83.1, | Acidic, used in the | |
77.05,54.9,43.05. | Adipic Acid Figure-19 | production of | |||
pharmaceuticals, | |||||
bactericides | |||||
19.970 | 7.826 | 270.24g/mol | MS: 260.29,256.3, | Apigenin Figure – 20 | Natural flavones, |
207.08,194.14,
161.15,148.13, 117.18,103.16. |
anti-oxidant, anti-inflammatory & anti – tumor properties | ||||
23.046 | 1.474 | 300.27g/mol | MS: 316.34,232.26, | Chrysoeriol Figure – 21 | Flavonoid, |
207.15,161.15,
148.13,131.2,103.09. |
anti-oxidant, anti –inflammatory properties | ||||
24.317 | 2.812 | 410.718g/mol | MS: 149.31,137.19, | Squalene Figure – 22 | emollient, |
121.23,95.211, 81.104,69.0843,68.105 | anti-oxidant |
NMR: NMR gives the largest amount of information about the structure of a compound. The comparison of the spectrum showed the presence of chemical constituents, namely, Piperine, Apigenin, Zingiberene and Squalene. Hence, H1 NMR analysis was done for the AMC sample to identify the components present in the sample. In the spectrum the peaks were seen, in the regions 5.9 – 7.0 ppm, 3.54ppm and 0.8 – 1.55ppm, indicating the presence of both aromatic and aliphatic regions. The NMR values were compared with the standard spectrum present in the SDBS database. Piperine–5.9–7.0 ppm, Apigenin – 3.54 ppm, Zingiberene– 0.8– 1.55 ppm, Squalene–0.91–5.04 ppm Fig. 14, 15, 16, 17.
FIG. 14, 15, 16, and 17: NMR OF AMC
HPTLC of AMC showed Withaferine A and Piperine 8. Flavonoids are used as ingredients in cosmetic products and drugs. Flavonoids also possesses anti - bacterial, anti - cancer and anti- oxidant properties 27. The present study of GC-MS and NMR analysis of the choornam also revealed the presence of the flavonoids piperine, apigenin and Zingiberene respectively. The total flavonoid content of AMC was found to be 0.328mg/1g. Many herbal formulations were found to exhibit hypoglycemic action. Those formulations mainly contain flavonoids. Flavonoids are known to be bioactive anti-diabetic principles. Flavonoid compounds such as Boswellic acid, Ellagic acid, Quercetin, and Rutin revealed a maximum reduction in blood glucose levels 28. Evaluation of AMC against chickengunya proved the anti-inflammatory action of the choornam 29.
CONCLUSION: Siddha medicines are our traditional medicines with lesser side effects. Since, they are plant-based products. The compound Piperine identified in the AMC increases the bioavailability of nutritional compounds, thus enhancing a person's briskness. Apigenin and Chrysoeriol have anti-inflammatory activity, thus validating the anti–rheumatoid arthritis activity of the choornam; the scientific validation of the Siddha system of medicine may give an approach for enhancing wealth.
Footnote:
Funding: Funding information is not applicable. No funding was received.
Ethics Statement: This article does not contain any studies with human participants or animals.
ACKNOWLEGEMENT: I am grateful to Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore for giving me the amazing opportunity to do the practical work. My sincere gratitude to Dr. Shubashini K Sripathi Madam, Professor, Department of chemistry, Avinashilingam Institute for Home Science and Higher Education for Women, for her tremendous assistance to write the manuscript.
CONFLICTS OF INTEREST: The authors declare no conflicts of interest.
REFERENCES:
- Saikat S, Raja C and Revival: Modernization and Integration of Indian Traditional Herbal Medicine in Clinical Practice Importance, Challenges and Future. Journal of Traditional and Complementary Medicine 2017; 7: 234-244.
- Sachan A, Garima V and Roopak K: Need of Standardization of Herbal Medicines in Modern Era. International Journal of Phytomedicine 2016; 8(3): 300-307.
- Adithan C: Pharmacological research in India 1972--1995 -- an analysis based on IPS Conferences (1996).
- Tandon V, Kapoor B and Gupta B M: Herbal drug research in India: A Trend Analysis Using IJP as a Marker (1995 – August 2003). Indian Journal of Pharmacology 2004; 36: 99-100.
- Aminu SA and Ruchi S: Comparative Analysis of Herbal and Allopathic Treatment System. European Journal of Molecular & Clinical Medicine 2020; 07(7): 2869-2876.
- Arjun R, Duraisamy A Joseph, Selvakumar B and Vijay P Singh: Medicinal plants from Siddha System of Medicine Useful for Treating Respiratory Diseases 2009; 2: 20-30.
- Kenneth G. Zysk: Siddha Medicine in Tamil Nadu. Tranquebar Initiativets Skriftserie 2008; 4: 20.
- Jeganathan NS, Kannan K, Manavalan R and Hannah RV: Standardization of a Siddha Formulation Amukkara Curanamby HPTLC. Complementary and Alternative Medicines 2008; 5(2): 131-140.
- Manjari V, Kalaivanan K and Banumathi V: Scientific Validation of Amukkara (Withaniasomnifera) Chooranum – Before and After Purification. International Journal of Current Research in Chemistry and Pharmaceutical Sciences 2018; 5(4): 56-64.
- Amala M, Vinodini R, Amala Hazel AM, Meenakshi Sundaram M and Banumathi V: Standardization of the Drug AmukkaraChooranam – a Siddha Polyherbal Formulation. World Journal of Pharmaceutical Research 2019; 8(1): 788 – 803.
- Sivaraman D, Anbu N, Kabilan N, Pitchiah Kumar M, Shanmugapriya P and Christian GJ: Exploration of Anti-Urolithiasis Potential of Traditional Siddha Formulations Amukkara Chooranam and Karisalai Karpam Chooranam by Struvite Crystal Growth Inhibition. Pharmacognosy Journal 2019; 11(4): 683-688.
- Kannan M, Sathiyarajeswaran P, Sasikumar D, Geetha A, Mohanapriya M, Vinod N.P, Manickam P, Kanakavalli K, Parthibhan P, Pitchiah Kumar P, Kannan R and Sivaraman G: Safety and efficacy of a Siddha Medicine fixed regimen for the treatment of asymptomatic and mild COVID-19 patients. Journal of Ayurveda and Integrative Medicine 2022; 13: 100589.
- Beema SR and Seema S: Modulatory effects of Amukkara Choornam on Candida albicans Biofilm: In-vitro and In-vivo Molecular Biology Reports 2019; 46: 2961–2969.
- Dayanand RG, Rama DB, Dasari P, and Vijaya NKG: A Comprehensive Review on Anti-Diabetic Formulations Employed in Siddha System of Medicine. The Journal of Phytopharmacology 2019; 8(3): 142-146.
- Sulekha MPS: Comprehensive Review on Medicinal Herb Withania somnifera (L.) Dunal in Women’s Health: a Rejuvenator from Siddha Medicine. Current Pharmacology Reports 2022; 72–77. https://doi.org/10.1007/s40495-021-00274-5s
- Thillaivanan S, Samraj K, Susikannamma S and Parthiban P: A pharmaceutical Review of Siddha Classical Preparations for the Management of COVID-19 at TPEC COBVID Care Centre, Vellore. Journal of Pharmaceutical Research International 2021; 33(44): 504 – 516.
- Kunle OF, Egharevba HO and Ahmadu PO: Standardization of Herbal Medicines – A Review. International Journal of Biodiversity and Conservation 2012; 4(3): 101-112.
- Bijauliya RK, Alok S, Chanchal DK and Kumar MA: Comprehensive Review on Standardization of Herbal Drugs. International Journal of Pharmaceutical Sciencesand Research 2017; 8(9): 3663-3677.
- Karthik CP, Jayaram K and Suresh P: Standardization of a Polyherbal Siddha Formulation, Amukkara Choornam. Indian J of Traditional Knowledge 2009; 8(3): 449-452.
- Daily life experience of Health, Ayurveda, Medicines, Complementary Therapies https://www.bimbima.com/ayurveda/amukkara-choornam-medicine-details/774/.
- Kokate CK, Gohkale SB and Purohit AP: A Text Book of Terpenoids. Pharmacognosy Kindle Edition, 21st Edition 2002.
- Meenu S, Sharma RG and Aakanksha S: Study of Physico Chemical Properties of Drug and Physiological Variation in Leaves of Andrographis paniculata (Burm.F,) Nees. Pharmaceutica Indica 2013; 3(1): 52-64.
- Harborne AJ: Phytochemical Methods a Guide to Modern Techniques of Plant Analysis. Springer Science & Business Media: 1998: 4-84.
- Ketan TS, Anuradha K. Gajjar and Jignasa KS: Drug Solubility: Importance and Enhancement Techniques. International Scholarly Research Network 2012. DOI: 10.5402/2012/195727.
- Ordonez A, Gomez JG, Vattuone MA and Isla MI: Antioxidant Activities of Sechium edule (Jacq.) Swart extracts. Food Chemistry 2006; 97: 452–458.
- Guo F, Fengchang W, Yunsong M, Yan H, Xiaoli Z, Wei M, John PG and Ying L: Characterization of Organic Matter of Plants from Lakes by Thermal Analysis in a N2 Atmosphere. Scientific Reports 2016; 6: 22877.
- Asad U, Sidra M, Syed L Badshah, Noreen K, Lubna G, Benjamin G Poulson, Abdul-H Emwas and Mariusz J: Important Flavonoids and Their Role as a Therapeutic Agent. Molecules 2020; 25: 5243.
- Ramulu J and Goverdhan P: Hypoglycemic and Antidiabetic Activity of Flavonoids: Boswellic Acid, Ellagic Acid, Quercetin, Rutinon Streptozotocin-Nicotinamide Induced Type 2 Diabetic Rats. International J of Pharmacy and Pharma Sciences 2012; 4(2): 251-256.
- Jaspreet J, Vimal N, Shivam C, Somnath P and Sujatha S: In-vivo Evaluation of Withania somnifera– Based Indian Traditional Formulation (Amukkara Choornam), Against Chikungunya Virus–Induced Morbidity and Arthralgia. Journal of Evidence-Based Integrative Medicine 2018; 23: 1-7.
How to cite this article:
Saravanan K, Venugopal S and Shilpa R: Standardization of Amukkara Chooranum- Siddha drug. Int J Pharm Sci & Res 2023; 14(6): 3101-09. doi: 10.13040/IJPSR.0975-8232.14(6).3101-09.
All © 2023 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
50
3101-3109
1058 KB
346
English
IJPSR
Kiruthika Saravanan, Sharulatha Venugopal * and R. Shilpa
Department of Chemistry, Avinashilingam Institute for Home Science and Higher Education for Women- Coimbatore, Tamil Nadu, India.
sharulatha_chem@avinuty.ac.in
21 October 2022
24 November 2022
28 November 2022
10.13040/IJPSR.0975-8232.14(6).3101-09
01 June 2023